Management ChangeJul 14, 2026, 04:07 PM
Propanc Biopharma Appoints Carlo Campiciano to Board
AI Summary
Propanc Biopharma, Inc. announced that Annie Van Broekhoven retired and stepped down from its Board of Directors effective July 8, 2026. Concurrently, the Board appointed Carlo Campiciano to fill the vacancy. Mr. Campiciano brings extensive experience as a qualified accountant, having served as CFO and Company Secretary of MedAdvisor Limited, where he played a key role in capital raising, ASX listing, and international expansion.
Key Highlights
- Annie Van Broekhoven retired and stepped down from Propanc Biopharma's Board of Directors effective July 8, 2026.
- Carlo Campiciano was appointed to the Board to fill the vacancy on the same day.
- Mr. Campiciano is a qualified accountant and member of the Institute of Public Accountants in Australia.
- He has extensive experience in taxation, finance operations, planning, and financial strategy.
- Mr. Campiciano previously served as CFO and Company Secretary of MedAdvisor Limited (ASX-listed).
- He was instrumental in MedAdvisor's capital raising, ASX listing, and expansion into the USA and Asia.
- He holds a Master of Entrepreneurship and Innovation and US GAAP certification.
Price Impact
More from PPCB